Tranexamic acid administration for arthroscopic rotator cuff repair: A prospective, double-blind, randomized controlled trial

氨甲环酸 医学 可视模拟标度 肩袖 随机对照试验 外科 麻醉 骨科手术 肩膀 安慰剂 失血 病理 替代医学
作者
Ryosuke Takahashi,Yukihiro Kajita,Yusuke Iwahori,Yohei Harada
出处
期刊:Journal of Orthopaedic Science [Elsevier BV]
卷期号:28 (2): 328-332 被引量:14
标识
DOI:10.1016/j.jos.2021.11.015
摘要

The purpose of this study was to compare the efficacy of tranexamic acid versus placebo after arthroscopic rotator cuff repair.This prospective, double-blind, and randomized study involved 66 patients who consecutively underwent arthroscopic rotator cuff repair from 2020 to 2021 at our hospital. Thirty-three shoulders each were randomly assigned to the tranexamic acid and control groups. In the former group, 1000 mg of tranexamic acid (20 mL) was administered intravenously 10 min before surgery and the same volume of normal saline (20 mL) was administered intravenously in the control group. We evaluated visual clarity; visual analog scale pain scores at rest, during activity, and at night; the circumference and diameter of the shoulder joint in the groups before and after the surgery at 1, 2, and 3 days, and 1 week; estimated perioperative blood loss; and operative time. Visual clarity was rated using a numeric rating scale from grade 1 (poor) to grade 3 (clear) every 15 min throughout the surgery. We compared and analyzed the results between the groups. Statistical significance was set at a p-value of <0.05.Visual clarity was found to be significantly better in the tranexamic acid group, with a greater percentage of grade 3 visual clarity (75.6 ± 11.2% vs 68.1 ± 13.4%, p = 0.045). The visual analog scale scores at rest and at night in the control group were significantly lower than those in the tranexamic acid group for 1 week postoperatively (13.8 ± 14.8 vs 5 ± 9.3, p = 0.008, 36.1 ± 23.3 vs 19.3 ± 24, p = 0.012). The circumference and diameter of the shoulder joint, estimated perioperative blood loss, and operative time were not significantly different between the two groups.Intravenous administration of tranexamic acid is an alternative way to improve visual clarity in arthroscopic rotator cuff repair; however, there are no other significant differences compared to the administration of placebo.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
田様应助你猜啊采纳,获得10
7秒前
8秒前
王359完成签到 ,获得积分10
9秒前
张秉环完成签到 ,获得积分10
9秒前
14秒前
Mifabric完成签到,获得积分10
14秒前
老肖发布了新的文献求助10
14秒前
17秒前
keyzymes完成签到,获得积分10
19秒前
yemuan完成签到,获得积分10
21秒前
22秒前
星河发布了新的文献求助10
22秒前
22秒前
康康完成签到,获得积分10
23秒前
shishikai发布了新的文献求助10
23秒前
ssy完成签到 ,获得积分10
25秒前
香蕉觅云应助135468采纳,获得10
25秒前
25秒前
小比熊完成签到,获得积分10
26秒前
科研通AI2S应助Jacky采纳,获得10
26秒前
科目三应助lls采纳,获得10
27秒前
云飞扬应助sumu采纳,获得10
27秒前
陶陶发布了新的文献求助10
28秒前
29秒前
量子星尘发布了新的文献求助10
30秒前
31秒前
英俊的铭应助科研通管家采纳,获得10
32秒前
我是老大应助科研通管家采纳,获得10
32秒前
完美世界应助科研通管家采纳,获得10
32秒前
酷波er应助科研通管家采纳,获得10
32秒前
32秒前
隐形曼青应助科研通管家采纳,获得10
33秒前
33秒前
汉堡包应助科研通管家采纳,获得10
33秒前
斯文败类应助shishikai采纳,获得10
33秒前
CodeCraft应助科研通管家采纳,获得10
33秒前
汉堡包应助sensen采纳,获得10
33秒前
晗晗有酒窝完成签到,获得积分10
33秒前
丘比特应助孤独的珩采纳,获得10
40秒前
hh完成签到,获得积分20
42秒前
高分求助中
The Mother of All Tableaux Order, Equivalence, and Geometry in the Large-scale Structure of Optimality Theory 2400
Ophthalmic Equipment Market by Devices(surgical: vitreorentinal,IOLs,OVDs,contact lens,RGP lens,backflush,diagnostic&monitoring:OCT,actorefractor,keratometer,tonometer,ophthalmoscpe,OVD), End User,Buying Criteria-Global Forecast to2029 2000
Optimal Transport: A Comprehensive Introduction to Modeling, Analysis, Simulation, Applications 800
Official Methods of Analysis of AOAC INTERNATIONAL 600
ACSM’s Guidelines for Exercise Testing and Prescription, 12th edition 588
A new approach to the extrapolation of accelerated life test data 500
T/CIET 1202-2025 可吸收再生氧化纤维素止血材料 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 冶金 细胞生物学 免疫学
热门帖子
关注 科研通微信公众号,转发送积分 3954469
求助须知:如何正确求助?哪些是违规求助? 3500461
关于积分的说明 11099572
捐赠科研通 3230989
什么是DOI,文献DOI怎么找? 1786217
邀请新用户注册赠送积分活动 869884
科研通“疑难数据库(出版商)”最低求助积分说明 801713